Circular Commitment Company
Taipei, TW· latest recorded location
Circular Commitment Company is named on 6 US grants and 4 published applications in this corpus. Its most frequent classification is A61K (Medicines and medical preparations).
- Granted patents
- 6
- Published applications
- 4
- Inventors
- 3
- Granted in 2026 so far
- 0
- Most recent grant
- 29 Jul 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2019 | 2 | 2 |
| 2020 | 0 | 0 |
| 2021 | 1 | 0 |
| 2022 | 2 | 1 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 1 | 1 |
By publication year.
Technology areas
Share of 10 documents
Recent patents
- Therapeutic biologic for treatment of hepatocellular carcinoma29 Jul 2025US 12,371,473 B2
- Therapeutic biologic for treatment of hepatocellular carcinoma1 Nov 2022US 11,485,771 B2
- Methods and agents for the diagnosis and treatment of hepatocellular carcinoma24 May 2022US 11,339,217 B2
- Therapeutic biologic for treatment of hepatocellular carcinoma2 Feb 2021US 10,906,959 B2
- Therapeutic biologic for treatment of hepatocellular carcinoma3 Sep 2019US 10,400,026 B2
- Therapeutic Biologic For Treatment Of Glioblastoma8 May 2025US 2025/0145689 A1
- Therapeutic Biologic For Treatment Of Hepatocellular Carcinoma24 Nov 2022US 2022/0372109 A1
- Therapeutic Biologic for Treatment of Hepatocellular Carcinoma7 Nov 2019US 2019/0338016 A1
- Methods And Agents For The Diagnosis And Treatment Of Hepatocellular Carcinoma10 Oct 2019US 2019/0309062 A1
Most cited
By later US patents
- Methods and agents for the diagnosis and treatment of hepatocellular carcinoma4US 10,370,445 B22019
- Therapeutic biologic for treatment of hepatocellular carcinoma4US 10,400,026 B22019
- Therapeutic biologic for treatment of hepatocellular carcinoma3US 10,906,959 B22021
- Methods and agents for the diagnosis and treatment of hepatocellular carcinoma2US 11,339,217 B22022